CBOE vs EBS · P/E 24, $29.50B cap vs rev $1.04B
Cboe Global Markets Inc (CBOE) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Cboe Global Markets Inc (CBOE) is a financial data & stock exchanges company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
CBOE does not have a complete income-statement cache yet.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
CBOE currently screens at market cap $29.50B and trailing P/E 24.1. EBS currently screens at market cap $416.4M.
Not investment advice. Open the CBOE and EBS stock pages for the full models.
Not investment advice.